323 related articles for article (PubMed ID: 33304929)
1. Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis.
Yan YD; Ding Z; Pan MM; Xia Q; Cui JJ; Wang LW; Zhang C; Gu ZC
Front Cardiovasc Med; 2020; 7():586020. PubMed ID: 33304929
[No Abstract] [Full Text] [Related]
2. Editor's Choice - Severe Bleeding Risks of Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism: A Network Meta-Analysis of Randomised Controlled Trials.
Chen J; Lv M; Wu S; Jiang S; Xu W; Qian J; Chen M; Fang Z; Zeng Z; Zhang J
Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):465-474. PubMed ID: 34973879
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis.
Wu S; Lv M; Chen J; Jiang S; Chen M; Fang Z; Zeng Z; Qian J; Xu W; Guan C; Zhang J
Support Care Cancer; 2022 Dec; 30(12):10407-10420. PubMed ID: 36318341
[TBL] [Abstract][Full Text] [Related]
4. Net clinical benefit of antithrombotic therapy in patients with heart failure and sinus rhythm: A network meta-analysis from 5 clinical trials.
Zhang C; Wang N; Shen NN; Kong LC; He J; Wu Y; Feng D; Gu ZC
Thromb Res; 2020 Jun; 190():122-128. PubMed ID: 32361051
[TBL] [Abstract][Full Text] [Related]
5. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer: A Systematic Review and Trade-Off Analysis From 9 Randomized Controlled Trials.
Yan YD; Zhang C; Shen L; Su YJ; Liu XY; Wang LW; Gu ZC
Front Pharmacol; 2018; 9():575. PubMed ID: 29946255
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.
Wang Y; Lv H; Li D; Chen C; Gu G; Sun Y; Yang X; Liu Y; Fang F; Liu J; Tse G; Xia Y
Front Pharmacol; 2019; 10():773. PubMed ID: 31354488
[No Abstract] [Full Text] [Related]
7. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis.
Arce-Huamani MA; Barboza JJ; Martínez-Herrera JF; Torres-Roman JS; Maguiña JL
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893585
[No Abstract] [Full Text] [Related]
8. Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta-analysis.
Ma F; Xu W; Chen J; Zhang J
Eur J Clin Pharmacol; 2023 Aug; 79(8):1013-1022. PubMed ID: 37310479
[TBL] [Abstract][Full Text] [Related]
9. Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis.
Riaz IB; Fuentes HE; Naqvi SAA; He H; Sipra QR; Tafur AJ; Padranos L; Wysokinski WE; Marshall AL; Vandvik PO; Montori V; Bryce AH; Liu H; Badgett RG; Murad MH; McBane RD
Mayo Clin Proc; 2022 Feb; 97(2):308-324. PubMed ID: 34172290
[TBL] [Abstract][Full Text] [Related]
10. Direct versus conventional anticoagulants for treatment of cancer associated thrombosis: a pooled and interaction analysis between observational studies and randomized clinical trials.
Gu ZC; Yan YD; Yang SY; Shen L; Kong LC; Zhang C; Wei AH; Li Z; Wang XH; Lin HW
Ann Transl Med; 2020 Feb; 8(4):95. PubMed ID: 32175388
[TBL] [Abstract][Full Text] [Related]
11. A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation.
Zhou LY; Yang SF; Zhang Z; Zhang C; Shen L; Gu ZC; Zuo XC
Front Physiol; 2018; 9():1644. PubMed ID: 30524307
[No Abstract] [Full Text] [Related]
12. Risk of nonmajor bleeding upon use of direct oral anticoagulants for preventing and treating venous thromboembolism: A network meta-analysis.
Chen J; Lv M; Jiang S; Wu S; Xu W; Qian J; Zeng Z; Chen M; Fang Z; Zhang J
Vasc Med; 2022 Dec; 27(6):565-573. PubMed ID: 36065470
[TBL] [Abstract][Full Text] [Related]
13. Direct Oral Anticoagulants in Patients With Active Cancer: A Systematic Review and Meta-Analysis.
Sabatino J; De Rosa S; Polimeni A; Sorrentino S; Indolfi C
JACC CardioOncol; 2020 Sep; 2(3):428-440. PubMed ID: 34396250
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants.
Ay C; Beyer-Westendorf J; Pabinger I
Ann Oncol; 2019 Jun; 30(6):897-907. PubMed ID: 30918939
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism: A systematic review and Bayesian network meta-analysis.
Ning H; Yang N; Ding Y; Chen H; Wang L; Han Y; Cheng G; Zou M
Med Clin (Barc); 2023 Mar; 160(6):245-252. PubMed ID: 36031454
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in cancer patients: a systematic review and meta-analysis on the efficacy and safety of different direct oral anticoagulants (DOACs).
Song X; Liu Z; Zeng R; Shao J; Liu B; Zheng Y; Liu C; Ye W
Ann Transl Med; 2021 Jan; 9(2):162. PubMed ID: 33569464
[TBL] [Abstract][Full Text] [Related]
17. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis.
Xin Z; Liu F; Du Y; Mao F; Wang X; Xu P; Li Z; Qian J; Yao J
Ann Palliat Med; 2020 Sep; 9(5):2970-2981. PubMed ID: 32787358
[TBL] [Abstract][Full Text] [Related]
18. Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis.
Fujisaki T; Sueta D; Yamamoto E; Buckley C; Sacchi de Camargo Correia G; Aronson J; Tallón de Lara P; Fujisue K; Usuku H; Matsushita K; Mehran R; Dangas GD; Tsujita K
JACC CardioOncol; 2024 Feb; 6(1):99-113. PubMed ID: 38510285
[TBL] [Abstract][Full Text] [Related]
19. Comparative Risks of Fracture Among Direct Oral Anticoagulants and Warfarin: A Systematic Review and Network Meta-Analysis.
Tsai SHL; Hu CW; Shao SC; Tischler EH; Obisesan OH; Vervoort D; Chen WC; Hu JR; Kuo LT
Front Cardiovasc Med; 2022; 9():896952. PubMed ID: 35677694
[TBL] [Abstract][Full Text] [Related]
20. Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis.
Fuentes HE; McBane RD; Wysokinski WE; Tafur AJ; Loprinzi CL; Murad MH; Riaz IB
Mayo Clin Proc; 2019 Dec; 94(12):2444-2454. PubMed ID: 31685262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
